Peginterferon alfa-2a [pegasys] and ribavirin in the treatment of chronic Hepatitis C
Hepatitis Monthly. 2004; 4 (7): 75-78
en Inglés
| IMEMR
| ID: emr-203600
ABSTRACT
Background and aims:
pegylation of interferon alfa-2a is a new modality for treatment of chronic hepatitis C. This clinical trial was conducted to evaluate the efficacy and safety of PEG IFN in combination with ribavirin in CHC patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Hepat. Monthly
Año:
2004
Similares
MEDLINE
...
LILACS
LIS